Literature DB >> 15845652

The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore.

Michela Ceschi1, Can-Lan Sun, David Van Den Berg, Woon-Puay Koh, Mimi C Yu, Nicole Probst-Hensch.   

Abstract

Cyclin D1 (CCND1), an intracellular cell-cycle regulatory protein with checkpoint function, can promote cell proliferation or induce growth arrest and apoptosis depending on the cellular context. We hypothesized that the direction of the association between the (CCND1) G870A-polymorphism and breast cancer risk may be modified by dietary and genetic factors influencing the oxidant-antioxidant balance, such as a dietary pattern with a high intake of n-6 fatty acids and a low intake of n-3 fatty acids, or a genetic profile that is deficient in glutathione S-transferases. We tested our hypothesis in a case-control study nested into the Singapore Chinese Health Study, a prospective investigation of diet and cancer in 63,000 Chinese men and women. Genomic DNA collected from 258 incident cases of breast cancer and 670 female cohort controls was examined for CCND1, GSTM1, GSTT1 and GSTP1 genes using fluorogenic 5'-nuclease assay. Unconditional logistic regression models were used to assess the effects with adjustment for potential confounders. All statistical tests were two-sided. The heterozygous CCND1 GA genotype significantly reduced the breast cancer risk in all subjects (OR=0.67, 95% CI 0.45-0.99) when compared with the GG genotype. The association was restricted to women with a high (above median value) intake level of n-6 fatty acids (OR=0.51, 95% CI 0.30-0.87), a low (below median value) intake level of the antagonistic marine n-3 fatty acids (OR=0.54, 95% CI 0.32-0.93) or a total lack of the antioxidative GSTM1 (OR=0.44, 95% CI 0.25-0.80) or GSTT1 genes (OR=0.46, 95% CI 0.24-0.87). The effects were consistently stronger in cases with advanced disease. The AA genotype did not affect breast cancer risk. The results of this study are compatible with the hypothesis that the oxidant-antioxidant balance in cells is an important determinant of the direction of the cyclin D1 effect, leading either to cell proliferation or cell death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845652     DOI: 10.1093/carcin/bgi093

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  22 in total

Review 1.  GSTT1 polymorphism and breast cancer risk in the Chinese population: an updated meta-analysis and review.

Authors:  Zhang-Sheng Xiao; Yun Li; Yan-Li Guan; Jia-Gen Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population.

Authors:  Jing Jiang; Jingweng Wang; Sadao Suzuki; Vendhan Gajalakshmi; Kiyonori Kuriki; Yang Zhao; Seiichi Nakamura; Susumu Akasaka; Hideki Ishikawa; Shinkan Tokudome
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-03       Impact factor: 4.553

3.  CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.

Authors:  Jing Ni; Meilin Wang; Miaomiao Wang; Shilong Fu; Delan Zhou; Zhengdong Zhang; Suping Han
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-15       Impact factor: 4.553

4.  Association of DNA repair and cell cycle gene variations with breast cancer risk in Northeast Indian population: a multiple interaction analysis.

Authors:  Mishi Kaushal Wasson; Pradeep Singh Chauhan; L C Singh; Dheeraj Katara; Jagannath Dev Sharma; Eric Zomawia; Amal Kataki; Sujala Kapur; Sunita Saxena
Journal:  Tumour Biol       Date:  2014-03-07

5.  Association of CCND1 Gene c.870G>A Polymorphism with Breast Cancer Risk: A Case-ControlStudy and a Meta-Analysis.

Authors:  Zahra Soleimani; Davood Kheirkhah; Mohammad Reza Sharif; Alireza Sharif; Mohammad Karimian; Younes Aftabi
Journal:  Pathol Oncol Res       Date:  2016-12-21       Impact factor: 3.201

6.  Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.

Authors:  Theodoros N Sergentanis; Konstantinos P Economopoulos
Journal:  Mol Biol Rep       Date:  2010-12-14       Impact factor: 2.316

7.  Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome.

Authors:  E K A Millar; J L Dean; C M McNeil; S A O'Toole; S M Henshall; T Tran; J Lin; A Quong; C E S Comstock; A Witkiewicz; E A Musgrove; H Rui; L Lemarchand; V W Setiawan; C A Haiman; K E Knudsen; R L Sutherland; E S Knudsen
Journal:  Oncogene       Date:  2009-03-16       Impact factor: 9.867

8.  A meta-analysis of the association of glutathione S-transferase P1 gene polymorphism with the susceptibility of breast cancer.

Authors:  Jun-Jie Liu; Jin-Lu Liu; Xing Zhang; Lu Xie; Jian Zeng
Journal:  Mol Biol Rep       Date:  2013-01-19       Impact factor: 2.316

9.  The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis.

Authors:  Changxi Zhou; Huaijie An; Mingdong Hu; Qinghui Liu; Peiliang Geng; Jiancheng Xu; Baojun Sun; Changting Liu
Journal:  Tumour Biol       Date:  2013-07-20

10.  Decreased PM10 exposure attenuates age-related lung function decline: genetic variants in p53, p21, and CCND1 modify this effect.

Authors:  Medea Imboden; Joel Schwartz; Christian Schindler; Ivan Curjuric; Wolfgang Berger; Sally L J Liu; Erich W Russi; Ursula Ackermann-Liebrich; Thierry Rochat; Nicole M Probst-Hensch
Journal:  Environ Health Perspect       Date:  2009-05-26       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.